Suppr超能文献

在瑞典国家患者登记处识别肠易激综合征:一项验证研究。

Identification of irritable bowel syndrome in the Swedish National Patient Register: a validation study.

机构信息

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Medicine, Ersta Hospital, Stockholm, Sweden.

出版信息

Scand J Gastroenterol. 2023 Jul;58(7):709-717. doi: 10.1080/00365521.2023.2173021. Epub 2023 Feb 1.

Abstract

BACKGROUND AND OBJECTIVE

National patient registers are valuable in epidemiological studies. To ensure high-quality data for studies of irritable bowel syndrome (IBS), this study aimed to validate the ICD-10 code for IBS in the Swedish National Patient Register.

METHODS

The positive predictive values (PPV) for IBS defined by the Rome criteria were calculated based on a review of medical records of randomly selected individuals with a first-ever diagnostic listing of IBS in the Swedish National Patient register in the year 2005 (Rome II criteria) or 2010 (Rome III criteria).

KEY RESULTS

340 medical records were reviewed (172 from 2005 and 168 from 2010). The majority of patients were females (74%), and the mean age was 42 years. IBS used in any type of department had a PPV of 76% (95% confidence interval 71-80%), which increased to 80% (76-84%) when we included individuals likely to have IBS but where information about some aspects of the Rome criteria was lacking in the medical record. Two highly specialized gastroenterological departments had the best PPV, 96%, while departments of internal medicine in general had a PPV of 82% (80-95%). The PPV for the IBS subtype was 62% (55-67%). The PPVs were not significantly different comparing the two time periods investigated.

CONCLUSION AND INFERENCES

The validity of a register-based definition of IBS in the Swedish National Patient register is high and can be used to identify patients with IBS in observational research. The data source, i.e., type of hospital and department, influences reliability.

摘要

背景与目的

国家患者登记处对于流行病学研究具有重要价值。为确保研究肠易激综合征(IBS)的高质量数据,本研究旨在验证瑞典国家患者登记处中用于 IBS 的 ICD-10 编码。

方法

基于对 2005 年(罗马 II 标准)或 2010 年(罗马 III 标准)首次在瑞典国家患者登记处诊断为 IBS 的随机个体的医疗记录进行审查,计算符合罗马标准定义的 IBS 的阳性预测值(PPV)。

主要结果

共审查了 340 份医疗记录(2005 年 172 份,2010 年 168 份)。大多数患者为女性(74%),平均年龄为 42 岁。在任何类型的科室中使用 IBS 的 PPV 为 76%(95%置信区间 71-80%),当我们将那些可能患有 IBS 但医疗记录中缺少罗马标准某些方面信息的个体包括在内时,PPV 增加到 80%(76-84%)。两个高度专业化的胃肠病学科室的 PPV 最高,为 96%,而一般内科科室的 PPV 为 82%(80-95%)。IBS 亚型的 PPV 为 62%(55-67%)。两个研究时间段的 PPV 无显著差异。

结论

瑞典国家患者登记处中基于登记的 IBS 定义的有效性较高,可用于观察性研究中识别 IBS 患者。数据来源,即医院和科室类型,会影响可靠性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验